Jobs / United States / Astrazeneca Pharmaceuticals Lp

Associate Director, Analytical Sciences – Potency & Bioassay Development

Astrazeneca Pharmaceuticals Lp · 🇺🇸 US – Santa Monica Colorado Avenue – CA

Sponsorship verdict

Sponsorship possible

One solid signal, not two — worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
  • What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
  • Confirmed live todayWhen a source last listed this job as open.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.

Start free →

Or apply yourself on the official page →

Sponsor Radar — Astrazeneca Pharmaceuticals Lp

99 H-1B filings certified since Oct 2025

The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).

Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →

About the role

At AstraZeneca, we are pushing the boundaries of science to deliver life-changing cell and gene therapies to patients. We are seeking a scientific leader to drive potency and functional bioassay development within our Analytical Sciences organization, supporting products from early development through commercialization. In this role, you will set the technical strategy for phase-appropriate potency and bioassay methods, build organizational capability in cell-line engineering and gene-editing-enabled analytics, and partner across CMC functions to ensure robust product characterization, release, stability, and comparability. You may also serve as Analytical Lead for programs advancing toward late-stage development and launch. This role is based out of Santa Monica, CA and reports to the Director, Product Analytical Sciences.  What You'll Do • Lead analytical strategy for potency and functional bioassays across the cell therapy portfolio, defining phase-appropriate approaches from early development to commercial launch. • Develop, qualify, validate, and lifecycle-manage cell-based potency and functional assays — including cytotoxicity, proliferation, activation, cytokine production, reporter-based assays, and multiparametric flow cytometry. • Build cell-line engineering and banking capabilities, including design of engineered target and reporter lines, clone selection, characterization, and critical reagent control to support transferable, commercial-ready methods. • Apply CRISPR/gene-editing, viral and non-viral delivery, and molecular biology expertise to enable analytics for autologous, allogeneic, and emerging in vivo therapies. • Drive method robustness using QbD, DOE, risk-based development, and sound statistical approaches. • Lead method transfer to internal QC, external labs, and manufacturing partners, including protocol and report authorship. • Partner with Process Development on process characterization, comparability, and linking process parameters to product quality attributes. • Serve as Analytical Lead on CMC program teams as appropriate, owning strategy, risks, timelines, and regulatory deliverables. • Author analytical sections of regulatory submissions (INDs through BLA) and responses to health authority queries. • Evaluate and implement emerging technologies and automation to improve robustness, throughput, and scalability. • Mentor and develop scientists, fostering strong experimental design and technical judgment across the team. Essential Qualifications   • PhD in Immunology, Cell Biology, Molecular Biology, Biochemistry, Bioengineering, or related discipline with 6+ years of relevant experience; or MS with 8+ years; or BS with 10+ years. • Substantial analytical development experience in cell therapy, gene therapy, or biologics within a regulated environment. • Proven expertise developing and qualifying cell-based potency/functional assays suitable for QC use. • Strong knowledge of immune cell biology (T-cell and/or NK-cell) and relevant signaling mechanisms. • Hands-on experience with multiparametric flow cytometry and other cell-based analytical platforms. • Deep understanding of the analytical method lifecycle — development, qualification, validation, transfer, and lifecycle management. • Experience authoring analytical content for regulatory submissions. • Demonstrated ability to lead cross-functional scientific programs and influence technical strategy. • Strong communication, mentorship, and scientific leadership skills. Preferred skills  • Direct experience engineering, characterizing, and banking mammalian cell lines as assay substrates, targets, or reporters. • Experience establishing critical reagent and cell bank strategies for late stage/commercial methods. • Experience w

View the official posting →

Source: Employer career site (Workday) First seen: 2026-10-08 Last confirmed: 2026-10-08 How our data works → Report this job

Similar opportunities